Prudential Financial Inc Biotechnology

Prudential Financial Inc

$70 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IOVA Iovance Biotherapeutics, Inc.	$917M	$161,000 0.0% of portfolio	17,248	Q3 2024 Reduced 75.85%
NVAX Novavax Inc	$660M	$132,000 0.0% of portfolio	10,463	Q3 2024 Reduced 0.62%
GBIO Generation Bio Co.	$44.8M	$125,000 0.0% of portfolio	50,975	Q2 2024 Added 23.8%
ARDX Ardelyx, Inc.	$838M	$114,000 0.0% of portfolio	16,550	Q3 2024 Reduced 0.63%
RAPT Rapt Therapeutics, Inc.	$33.8M	$107,000 0.0% of portfolio	53,645	Q2 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.37B	$105,000 0.0% of portfolio	16,070	Q3 2024 Reduced 53.4%
OCUL Ocular Therapeutix, Inc	$581M	$100,000 0.0% of portfolio	11,525	Q3 2024 Reduced 0.6%
APLT Applied Therapeutics Inc.	$27.4M	$95,000 0.0% of portfolio	11,280	Q3 2024 New
AKBA Akebia Therapeutics, Inc.	$395M	$85,000 0.0% of portfolio	64,469	Q3 2024 Added 351.81%
XERS Xeris Biopharma Holdings, Inc.	$488M	$85,000 0.0% of portfolio	29,945	Q3 2024 New
HRTX Heron Therapeutics, Inc.	$201M	$84,000 0.0% of portfolio	42,515	Q3 2024 Added 39.32%
CDXC Chroma Dex Corp.	$379M	$83,000 0.0% of portfolio	22,815	Q2 2024 Reduced 11.57%
FULC Fulcrum Therapeutics, Inc.	$198M	$80,000 0.0% of portfolio	22,675	Q3 2024 New
NKTR Nektar Therapeutics	$152M	$73,000 0.0% of portfolio	56,260	Q2 2024 Added 39.95%
ADPT Adaptive Biotechnologies Corp	$1.05B	$72,000 0.0% of portfolio	14,214	Q3 2024 Added 21.85%
CCCC C4 Therapeutics, Inc.	$164M	$68,000 0.0% of portfolio	12,025	Q2 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$212M	$62,000 0.0% of portfolio	19,400	Q3 2024 New
KPTI Karyopharm Therapeutics Inc.	$49.5M	$61,000 0.0% of portfolio	74,600	Q3 2024 New
PSTX Poseida Therapeutics, Inc.	$815M	$57,000 0.0% of portfolio	19,980	Q2 2024 New
RPTX Repare Therapeutics Inc.	$51.2M	$56,000 0.0% of portfolio	16,400	Q3 2024 Added 20.59%
KRON Kronos Bio, Inc.	$55.6M	$55,000 0.0% of portfolio	55,800	Q2 2024 New
AADI Aadi Bioscience, Inc.	$57.6M	$54,000 0.0% of portfolio	26,400	Q3 2024 New
IKNA Ikena Oncology, Inc.	$51.8M	$51,000 0.0% of portfolio	29,800	Q2 2024 Added 76.12%
GOSS Gossamer Bio, Inc.	$96.8M	$46,000 0.0% of portfolio	47,050	Q3 2024 New
CLSD Clearside Biomedical, Inc.	$58.4M	$44,000 0.0% of portfolio	35,400	Q2 2024 Added 75.25%
CTMX Cytom X Therapeutics, Inc.	$56.1M	$43,000 0.0% of portfolio	36,500	Q2 2024 Added 14.42%
MCRB Seres Therapeutics, Inc.	$103M	$41,000 0.0% of portfolio	43,470	Q3 2024 Reduced 9.57%
BOLT Bolt Biotherapeutics, Inc.	$18.4M	$38,000 0.0% of portfolio	59,200	Q3 2024 Added 8.82%
ERAS Erasca, Inc.	$215M	$28,000 0.0% of portfolio	10,371	Q3 2024 Reduced 82.37%
NUVB Nuvation Bio Inc.	$493M	$28,000 0.0% of portfolio	12,215	Q2 2024 New
IPSC Century Therapeutics, Inc.	$45.9M	$25,000 0.0% of portfolio	15,150	Q2 2024 Added 28.17%
PRQR Pro Qr Therapeutics N.V.	$157M	$24,000 0.0% of portfolio	13,200	Q3 2024 New
OCGN Ocugen, Inc.	$156M	$23,000 0.0% of portfolio	23,910	Q3 2024 Reduced 46.04%
TSHA Taysha Gene Therapies, Inc.	$75M	$22,000 0.0% of portfolio	11,190	Q2 2024 Reduced 41.26%
VXRT Vaxart, Inc.	$88.6M	$22,000 0.0% of portfolio	25,900	Q2 2024 Added 121.37%
BLUE Bluebird Bio, Inc.	$542M	$17,000 0.0% of portfolio	34,205	Q3 2024 Added 189.75%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.